OBJECTIVE: To systematically review cohort studies of mortality among people who inject
drugs, examine mortality rates and causes of death in this group, and identify participant-and …

Human T-lymphotropic virus type II (HTLV-II) is a human retrovirus which is endemic in
Amerindian and pygmy tribes. Molecular subtypes show geographic segregation consistent …

ContextConflicting reports exist regarding the effect of hepatitis C virus (HCV) on the
progression of human immunodeficiency virus (HIV) disease. ObjectiveTo assess the effect …

Drug overdose is a common cause of non-AIDS death among people with HIV and the
leading cause of death for people who inject drugs. People with HIV are often exposed to …

Design: Systematic review and meta-analysis of cohorts of people with OUD involving illicit
opioids with data on all-cause or overdose-specific mortality. Setting and Participants: Of …

The goal of this study was to investigate clinical outcomes and survival probabilities among
persons coinfected with human immunodeficiency virus (HIV) and human T lymphotropic …

Human T-cell lymphotropic viruses type 1 and 2 are retroviruses that share the same routes
of transmission as HIV-1. Since these agents are prevalent simultaneously in different parts …

Background Young injection drug users (IDUs) may be at increased risk of premature
mortality due to the health risks associated with injection drug use including overdoses and …

Background: Injecting drug use (IDU) and associated mortality appear to be increasing in
many parts of the world. IDU is an important factor in HIV transmission. In estimating AIDS …

Directly administered antiretroviral therapy (DAART) is one approach to improving
adherence to among human immunodeficiency virus (HIV)—infected drug users. We …